These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 23203929)

  • 1. Association between magnitude of the virus-specific plasmablast response and disease severity in dengue patients.
    Garcia-Bates TM; Cordeiro MT; Nascimento EJ; Smith AP; Soares de Melo KM; McBurney SP; Evans JD; Marques ET; Barratt-Boyes SM
    J Immunol; 2013 Jan; 190(1):80-7. PubMed ID: 23203929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. B Cell Responses during Secondary Dengue Virus Infection Are Dominated by Highly Cross-Reactive, Memory-Derived Plasmablasts.
    Priyamvada L; Cho A; Onlamoon N; Zheng NY; Huang M; Kovalenkov Y; Chokephaibulkit K; Angkasekwinai N; Pattanapanyasat K; Ahmed R; Wilson PC; Wrammert J
    J Virol; 2016 Jun; 90(12):5574-85. PubMed ID: 27030262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dominant cross-reactive B cell response during secondary acute dengue virus infection in humans.
    Zompi S; Montoya M; Pohl MO; Balmaseda A; Harris E
    PLoS Negl Trop Dis; 2012; 6(3):e1568. PubMed ID: 22448292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protection from secondary dengue virus infection in a mouse model reveals the role of serotype cross-reactive B and T cells.
    Zompi S; Santich BH; Beatty PR; Harris E
    J Immunol; 2012 Jan; 188(1):404-16. PubMed ID: 22131327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid and massive virus-specific plasmablast responses during acute dengue virus infection in humans.
    Wrammert J; Onlamoon N; Akondy RS; Perng GC; Polsrila K; Chandele A; Kwissa M; Pulendran B; Wilson PC; Wittawatmongkol O; Yoksan S; Angkasekwinai N; Pattanapanyasat K; Chokephaibulkit K; Ahmed R
    J Virol; 2012 Mar; 86(6):2911-8. PubMed ID: 22238318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High frequency of pre-existing neutralizing antibody responses in patients with dengue during an outbreak in Central Brazil.
    de Teive E Argolo AF; de Rezende Féres VC; Cordeiro MT; da Silveira LA; Guilarde AO; de Azevedo Marques ET; de Souza WV; Martelli CM
    BMC Infect Dis; 2016 Oct; 16(1):546. PubMed ID: 27717314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunological and viral determinants of dengue severity in hospitalized adults in Ha Noi, Viet Nam.
    Fox A; Le NM; Simmons CP; Wolbers M; Wertheim HF; Pham TK; Tran TH; Trinh TM; Nguyen TL; Nguyen VT; Nguyen DH; Farrar J; Horby P; Taylor WR; Nguyen VK
    PLoS Negl Trop Dis; 2011 Mar; 5(3):e967. PubMed ID: 21390156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Role of Heterotypic DENV-specific CD8
    Talarico LB; Batalle JP; Byrne AB; Brahamian JM; Ferretti A; García AG; Mauri A; Simonetto C; Hijano DR; Lawrence A; Acosta PL; Caballero MT; Paredes Rojas Y; Ibañez LI; Melendi GA; Rey FA; Damonte EB; Harris E; Polack FP
    EBioMedicine; 2017 Jun; 20():202-216. PubMed ID: 28483582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dengue virus infection-enhancement activity in neutralizing antibodies of healthy adults before dengue season as determined by using FcγR-expressing cells.
    Ly MHP; Moi ML; Vu TBH; Tun MMN; Saunders T; Nguyen CN; Nguyen AKT; Nguyen HM; Dao TH; Pham DQ; Nguyen TTT; Le TQM; Hasebe F; Morita K
    BMC Infect Dis; 2018 Jan; 18(1):31. PubMed ID: 29321001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasmablasts During Acute Dengue Infection Represent a Small Subset of a Broader Virus-specific Memory B Cell Pool.
    Appanna R; Kg S; Xu MH; Toh YX; Velumani S; Carbajo D; Lee CY; Zuest R; Balakrishnan T; Xu W; Lee B; Poidinger M; Zolezzi F; Leo YS; Thein TL; Wang CI; Fink K
    EBioMedicine; 2016 Oct; 12():178-188. PubMed ID: 27628668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasmablasts generated during repeated dengue infection are virus glycoprotein-specific and bind to multiple virus serotypes.
    Xu M; Hadinoto V; Appanna R; Joensson K; Toh YX; Balakrishnan T; Ong SH; Warter L; Leo YS; Wang CI; Fink K
    J Immunol; 2012 Dec; 189(12):5877-85. PubMed ID: 23152560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lower IgG somatic hypermutation rates during acute dengue virus infection is compatible with a germinal center-independent B cell response.
    Godoy-Lozano EE; Téllez-Sosa J; Sánchez-González G; Sámano-Sánchez H; Aguilar-Salgado A; Salinas-Rodríguez A; Cortina-Ceballos B; Vivanco-Cid H; Hernández-Flores K; Pfaff JM; Kahle KM; Doranz BJ; Gómez-Barreto RE; Valdovinos-Torres H; López-Martínez I; Rodriguez MH; Martínez-Barnetche J
    Genome Med; 2016 Feb; 8(1):23. PubMed ID: 26917418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutralizing antibody titers against dengue virus correlate with protection from symptomatic infection in a longitudinal cohort.
    Katzelnick LC; Montoya M; Gresh L; Balmaseda A; Harris E
    Proc Natl Acad Sci U S A; 2016 Jan; 113(3):728-33. PubMed ID: 26729879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complexity of Neutralizing Antibodies against Multiple Dengue Virus Serotypes after Heterotypic Immunization and Secondary Infection Revealed by In-Depth Analysis of Cross-Reactive Antibodies.
    Tsai WY; Durbin A; Tsai JJ; Hsieh SC; Whitehead S; Wang WK
    J Virol; 2015 Jul; 89(14):7348-62. PubMed ID: 25972550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lower activation-induced T-cell apoptosis is related to the pathological immune response in secondary infection with hetero-serotype dengue virus.
    Yang W; Yan H; Ma Y; Yu T; Guo H; Kuang Y; Ren R; Li J
    Immunobiology; 2016 Mar; 221(3):432-9. PubMed ID: 26655144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potent Plasmablast-Derived Antibodies Elicited by the National Institutes of Health Dengue Vaccine.
    Magnani DM; Silveira CGT; Ricciardi MJ; Gonzalez-Nieto L; Pedreño-Lopez N; Bailey VK; Gutman MJ; Maxwell HS; Domingues A; Costa PR; Ferrari L; Goulart R; Martins MA; Martinez-Navio JM; Fuchs SP; Kalil J; Timenetsky MDC; Wrammert J; Whitehead SS; Burton DR; Desrosiers RC; Kallas EG; Watkins DI
    J Virol; 2017 Nov; 91(22):. PubMed ID: 28878078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenotype and functionality of follicular helper T cells in patients with acute dengue infection.
    Wijesinghe A; Gamage J; Goonewardena H; Gomes L; Jayathilaka D; Wijeratne DT; de Alwis R; Jeewandara C; Wijewickrama A; Ogg GS; Malavige GN
    J Biomed Sci; 2020 Apr; 27(1):50. PubMed ID: 32264870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation between dengue-specific neutralizing antibodies and serum avidity in primary and secondary dengue virus 3 natural infections in humans.
    Puschnik A; Lau L; Cromwell EA; Balmaseda A; Zompi S; Harris E
    PLoS Negl Trop Dis; 2013; 7(6):e2274. PubMed ID: 23785536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetics of viremia and NS1 antigenemia are shaped by immune status and virus serotype in adults with dengue.
    Tricou V; Minh NN; Farrar J; Tran HT; Simmons CP
    PLoS Negl Trop Dis; 2011 Sep; 5(9):e1309. PubMed ID: 21909448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasmablast Expansion Following the Tetravalent, Live-Attenuated Dengue Vaccine Butantan-DV in DENV-Naïve and DENV-Exposed Individuals in a Brazilian Cohort.
    Silveira CGT; Magnani DM; Costa PR; Avelino-Silva VI; Ricciardi MJ; Timenetsky MDCST; Goulart R; Correia CA; Marmorato MP; Ferrari L; Nakagawa ZB; Tomiyama C; Tomiyama H; Kalil J; Palacios R; Precioso AR; Watkins DI; Kallás EG
    Front Immunol; 2022; 13():908398. PubMed ID: 35837409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.